Filing Details
- Accession Number:
- 0001209191-12-037463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-05 21:17:14
- Reporting Period:
- 2012-07-03
- Filing Date:
- 2012-07-05
- Accepted Time:
- 2012-07-05 20:17:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1491576 | Tesaro Inc. | TSRO | Pharmaceutical Preparations (2834) | 272249687 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1276600 | Khaled Nasr | 2710 Sand Hill Road Suite 200 Menlo Park CA 94025 | No | No | Yes | No | |
1460207 | Interwest Management Partners X, Llc | 2710 Sand Hill Road Suite 200 Menlo Park CA 94025 | No | No | Yes | No | |
1553019 | Keval Desai | 2710 Sand Hill Road Suite 200 Menlo Park CA 94025 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-03 | 2,627,257 | $0.00 | 2,627,257 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2012-07-03 | 444,444 | $13.50 | 3,071,701 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2012-07-03 | 9,195,402 | $0.00 | 2,627,257 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- The Series B Preferred Stock converted into shares of TESARO, Inc. common stock on a 3.5 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
- Reflects a 1-for-3.5 reverse stock split which beame effective on June 18, 2012
- The shares are owned by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10. Harvey B. Cash, Bruce A. Cleveland, Christopher B. Ehrlich, Philip T. Gianos, W. Stephen Holmes, Nina S. Kjellson, Gilbert H. Kliman, Arnold L. Oronsky, Douglas A. Pepper and Thomas L. Rosch are managing directors of IMP10. Keval Desai and Khaled A. Nasr are venture members of IMP10. Each managing director and venture member of IMP10 disclaims beneficial ownership of such shares, except to the extent of their pecuniary interest therein.